UPDATE 1-Mylan shareholders re-elect board, vote against executive pay
June 22, 2017 at 10:37 AM EDT
AMSTERDAM, June 22 (Reuters) - Mylan NV shareholders re-elected the generic drugmaker's board at its annual meeting on Thursday, despite a shareholder campaign to vote down most of the directors in the wake of a scandal related to its high prices for emergency allergy treatment EpiPen.
